RxDoctor Payments Data

Ronald Levy

Medical Oncology · Stanford, CANPI 1851427025

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $451,721 of the $475,010 with a category attached, or 95.1%. Amgen accounts for 74.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $368,066 and has fallen 94.6% since, to $20,058 in 2025. Among medical oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$475,010in general payments, 2019–2025

Across 30 payments — averaging $15,834 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$352K
  • Beigene, Ltd.$85K
  • OPKO Pharmaceuticals, LLC$20K
  • Beone Medicines USA, Inc.$12K
  • Beone Medicines Ltd.$3K
  • Pfizer$3K
  • plus $88 from 1 others
$317,596in research payments, 2019–2025

Across 30 payments — averaging $10,587 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$224K
  • E.r. Squibb & Sons, L.L.C.$68K
  • Pfizer$26K

What the payments were for

  • Consulting fees$451,72195%
  • Speaking & faculty fees$23,2005%
  • Food & beverage$880%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$475,010 in reported general payments places this provider in the 95th percentile of 379 medical oncology providers in California.

See all medical oncology providers in California →

Other medical oncology in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →